This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

hypo into molecule

Innovative Vaccines against Resistant Infectious Diseases and Emerging Threats

Monday, May 20, 2019

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

 

The development of vaccines against infectious diseases, beginning a few centuries ago, have had a profound impact on human health and longevity. While there are still many serious and potentially preventable infectious diseases for which no effective vaccines are available, the biotech revolution and advances in our understanding of the immune response hold promise to address these challenges. To explore the state of the science today, this symposium will gather the world’s leaders in vaccine development. Together, they will share the latest findings that illuminate the potential and the limits of the human immune system in its response to vaccines, the challenges facing vaccine development, maternal immunizations, and the next era of vaccine technologies.

Call for Abstracts

Abstract submissions are invited for a poster session and selected short talks. For complete submission instructions, please visit our online portal. The deadline for abstract submission is Friday, March 22, 2019. 

Registration

Member
By 04/19/2019
$90
After 04/19/2019
$130
Nonmember Academia, Faculty, etc.
By 04/19/2019
$180
After 04/19/2019
$260
Nonmember Corporate, Other
By 04/19/2019
$250
After 04/19/2019
$350
Nonmember Not for Profit
By 04/19/2019
$180
After 04/19/2019
$260
Nonmember Student, Undergrad, Grad, Fellow
By 04/19/2019
$100
After 04/19/2019
$145
Member Student, Post-Doc, Fellow
By 04/19/2019
$50
After 04/19/2019
$70
Earlybird Registration:
26
days
left
Deadline:
0
days
left

Keynote Speaker

Padmini Srikantiah, MD, MPH

Bill & Melinda Gates Foundation

Speakers

James E. Crowe, Jr., MD

Vanderbilt University

Ann Ginsberg, MD, PhD

International AIDS Vaccine Initiative

Gregory Glenn, MD

Novavax

Adrian Hill, PhD

University of Oxford

Kathrin Jansen, PhD

Pfizer

Wayne Koff, PhD

Human Vaccines Project

Sallie Permar, MD

Duke University

Bali Puelndran, PhD

Emory University

Rino Rappuoli, PhD

GlaxoSmithKline

David Weiner, PhD

The Wistar Institute

Drew Weissman, MD, PhD

University of Pennsylvania

Ian Wilson, DPhil

The Scripps Research Institute

Organizers

Annaliesa Anderson, PhD

Pfizer

Melanie Brickman Borchard, PhD, MSc

The New York Academy of Sciences

Gregory Glenn, MD

Novavax

Wayne Koff, PhD

Human Vaccines Project

Stanley Plotkin, MD
George Zavoico, PhD

B. Riley FBR

Event Sponsors




Monday

May 20, 2019

8:20 AM

Registration, Breakfast, and Poster Setup

8:50 AM

Welcome Remarks

Speaker

Melanie Brickman Borchard, PhD, MSc
The New York Academy of Sciences
9:00 AM

Keynote Presentation

Speaker

Padmini Srikantiah, MD, MPH
Bill & Melinda Gates Foundation

Session I: New Approaches for Understanding the Immune System for Vaccine Development

9:35 AM

Human Antibodies and Repertoires for Emerging Infectious Diseases

Speaker

James E. Crowe, Jr., MD
Vanderbilt University
10:00 AM

Modulating Antibody Functionality in Infectious Disease and Vaccination

Speaker

Bali Pulendran, PhD
Emory University
10:25 AM

Networking Coffee Break

Session II: Taking on the Big Challenges Facing Novel Vaccine Development

10:55 AM

New Generation Malaria Vaccines

Speaker

Adrian Hill, PhD
University of Oxford
11:20 AM

TB Vaccine Development

Speaker

Ann Ginsberg, PhD, MD
International AIDS Vaccine Initiative
11:45 AM

Title to Be Announced

Speaker

Wayne Koff, PhD
Human Vaccines Project
12:10 PM

2 Data Blitz Talks from Selected Abstracts

12:20 PM

Networking Luncheon and Poster Session

Session III: Vaccines to Protect Newborns: The Next Frontier

1:50 PM

Advances in Maternal Immunization

Speaker

Kathrin Jansen, PhD
Pfizer
2:15 PM

Protecting Infants from RSV via Maternal Immunization

Speaker

Greg Glenn, MD
Novavax
2:40 PM

Next Generation Vaccines against Cytomegalovirus: We Are Half Way There

Speaker

Sallie Permar, MD, PhD
Duke University
3:05 PM

Networking Coffee Break and Poster Session

Session IV: New Technologies for Vaccine Development

3:35 PM

Guiding Vaccine Candidates: Antibodies That Can Neutralize Influenza and Malaria

Speaker

Ian Wilson, DPhil
The Scripps Research Institute
3:50 PM

Synthetic DNA Approaches for Difficult Infectious Disease Targets

Speaker

David Weiner, PhD
The Wistar Institute
4:15 PM

mRNA Vaccines — a New Era in Vaccinology

Speaker

Drew Weissman, MD, PhD
University of Pennsylvania
4:40 PM

Transforming New Technologies into Vaccines: Genomics, Adjuvants and Self-Amplifying RNAs

Speaker

Rino Rappuoli, PhD
GlaxoSmithKline
5:05 PM

Closing Remarks

Speaker

Melanie Brickman Borchard, PhD
The New York Academy of Sciences
5:15 PM

Adjourn